Proliferation of double negative (DN) gammadelta T cells in reseponse to allogeneic MHC antigen.
Proliferation of double negative (DN) gammadelta T cells in reseponse to allogeneic MHC antigen.
批准号:
02670206
负责人:
NAKAYAMA Eiichi
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. In TL transgenic mouse strain C3H.Tg.Tla^a-3.1, gammadelta T cells start to increase from three weeks after birth and reach to about 30% of total T cells in peripheral lymphoid tisene. It was demonstrated that gammadelta T cells in these mice respond to proliferate in stimulation with immobilized anti-TCR delta mAb.2. Spleen cells from C3H.Tg.Tla^a-3.1 mice proliferated in response to mitomycin C (MMC) treated BALB/c stimulator cells. In these cultures, proliferative response was observed with gammadelta as well as alphabeta T cells. However, when alphabeta T cells were eliminated before MLC, no prolifenation was observed with gammadelta T cells. Thus, proliferative response of gammadelta T cells was dependent on alphabeta T cells. gammadelta T cells recovered after MLR culture showed no cytotoxicity against ^<51>Cr-labeled BALB/c target cells.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Yamamoto,H.et al.: "Roles of CD8^+ and CD4^+ cells in islet allograft rejection" Transplantation. 50. 120-125 (1990)
Yamamoto,H.et al.:“CD8^ 和 CD4^ 细胞在胰岛同种异体移植排斥中的作用”移植。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
三重野政広: "細胞傷害性CD4^-CD8^-TCRαβT細胞" 臨床免疫. 24. 1440-1447 (1992)
Masahiro Mieno:“细胞毒性 CD4^-CD8^-TCRαβT 细胞”临床免疫学 24. 1440-1447 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mieno, M., Suto, R., Obata, Y., Udono, H., Takahashi, T., Shiku, H., and Nakayama, E.: "CD4 CD8 T cell receptor alphabeta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic t
Mieno, M.、Suto, R.、Obata, Y.、Udono, H.、Takahashi, T.、Shiku, H. 和 Nakayama, E.:“CD4 CD8 T 细胞受体 Alphata T 细胞:in 的产生
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Use of long overlapping peptides for cancer vaccine and Treg control for potentiating immune response
-
批准号:22300332
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:2010
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Analysis of human tumor antigens and immune responses in patients
-
批准号:17016048
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$47.68万
-
财政年份:2005
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Tumor immune escape and the role of CD4 regulatory T cells
-
批准号:13670319
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.7万
-
财政年份:2001
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Tumor immune escape by immunoregulatory CD4 T cells
-
批准号:10670304
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:1998
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Induction of immune response against MHC class I-binding peptides
-
批准号:07670372
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:NAKAYAMA Eiichi
-
依托单位:
Cellular mechanisms of graft rejection mediated by CD4-CD8-TCR alphabeta T cells.
-
批准号:04454210
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$0.77万
-
财政年份:1992
-
负责人:NAKAYAMA Eiichi
-
依托单位:
海外基金